CRH
CRH PLC
CRH PLC historical holders
total: 6
Egerton Capital CRH PLC transactions over time
- Total transactions:
- 11
- New positions:
- 1
- Added:
- 5
- Reduced:
- 5
- Held since:
- 2023 Q4
- Held for:
- 11 quarters
- Latest activity:
- 2026 Q2
John Armitage has been an institutional investor in CRH PLC (CRH) since 2023 Q4. According to 2026 Q2 report, John Armitage holds 4,383,866 shares with a market value of roughly $469.07M representing 4.53% of their equity portfolio. The fund/company first acquired CRH in 2023 Q4, initially purchasing about 3.39M shares. Since the initial investment, Egerton Capital has made 10 more transactions in this position.
Does John Armitage still hold CRH?
Yes, John Armitage continues to hold CRH PLC (CRH). According to their 2026 Q2 report, they maintain a position of 4,383,866 shares valued at approximately $469.07M, representing 4.53% of their equity portfolio.
When did John Armitage first invest in CRH?
John Armitage first invested in CRH PLC (CRH) in 2023 Q4 at the reported quarter-end price of $69.16 per share, acquiring 3,393,265 shares in their initial purchase.
What is John Armitage's average cost basis for CRH?
Based on historical transaction data, John Armitage's estimated cost basis for CRH PLC (CRH) is approximately $84.87 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $84.87
- Weighted AVG sell price:
- $116.69
CRH transactions history by Egerton Capital
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
4.53%
|
4,383,866
|
$107.00
|
$469,073,662
|
+58.87% (+1,624,535)
|
+1.68%
|
|
2026 Q1
|
3.22%
|
2,759,331
|
$105.12
|
$290,060,875
|
+22.04% (+498,271)
|
+0.58%
|
|
2025 Q4
|
3.07%
|
2,261,060
|
$124.80
|
$282,180,288
|
-46.93% (-1,999,786)
|
-2.63%
|
|
2025 Q3
|
5.39%
|
4,260,846
|
$119.90
|
$510,875,435
|
-6.78% (-309,718)
|
-0.38%
|
|
2025 Q2
|
4.30%
|
4,570,564
|
$91.80
|
$419,577,775
|
+8.02% (+339,328)
|
+0.32%
|
|
2025 Q1
|
4.29%
|
4,231,236
|
$87.97
|
$372,221,831
|
-2.26% (-97,656)
|
-0.1%
|
|
2024 Q4
|
4.63%
|
4,328,892
|
$92.52
|
$400,509,088
|
-1.96% (-86,766)
|
-0.08%
|
|
2024 Q3
|
4.13%
|
4,415,658
|
$92.74
|
$409,508,123
|
+12.06% (+475,305)
|
+0.44%
|
|
2024 Q2
|
2.98%
|
3,940,353
|
$74.98
|
$295,447,668
|
-6.97% (-295,084)
|
-0.21%
|
|
2024 Q1
|
3.53%
|
4,235,437
|
$86.26
|
$365,348,796
|
+24.82% (+842,172)
|
+0.7%
|
|
2023 Q4
|
2.54%
|
$69.16
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.